Patents by Inventor Angela Gonzalez de Castro

Angela Gonzalez de Castro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXIDATION OF SANTALENE TO SANTALOL
    Publication number: 20220371976
    Abstract: The invention relates to a process for the oxidation of santalene to santalol. The starting material is in particular a mixture comprising alpha-santalene, beta-santalene, epi-beta-santalene, trans-alpha-bergamotene and beta-bisabolene. The oxidation of the santalenes occurs via an intermediate chloro-santalene compound. Substitution of the chloro-substituent by acetate yielded the mixture of the corresponding santalyl actates, which were hydrolyzed to yield the corresponding mixture of santalols.
    Type: Application
    Filed: September 25, 2020
    Publication date: November 24, 2022
    Inventors: Dominique CALLANT, Paul ALSTERS, Karin DAUTZENBERG, Angela GONZALEZ DE CASTRO, Robert TROKOWSKI
  • Boronic acid derivatives and synthesis thereof
    Patent number: 11286270
    Abstract: Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, ?-lactamase inhibitors (BLIs).
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: March 29, 2022
    Assignee: Qpex Biopharma, Inc.
    Inventors: Scott J. Hecker, Serge Henri Boyer, Hubertus J. A. Dielemans, Angela Gonzalez de Castro, Andreas H. M. de Vries, Laurent Lefort
  • BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF
    Publication number: 20200407373
    Abstract: Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, ?-lactamase inhibitors (BLIs).
    Type: Application
    Filed: October 10, 2018
    Publication date: December 31, 2020
    Inventors: Scott J. Hecker, Serge Henri Boyer, Hubertus J. A. Dielemans, Angela Gonzalez de Castro, Andreas H. M. de Vries, Laurent Lefort